Ohlfest
Carsten Ohlfest, Glueckstadt DE
Patent application number | Description | Published |
---|---|---|
20090074518 | Arrangement for Noise Reduction in Vacuum Systems - The present invention relates to an arrangement for adapting the transportation behaviour of material to be conveyed, which arrangement comprises a first container, which is coupleable to a first pressure level; a second container, which is coupleable to a second pressure level; a connecting line for transporting material to be conveyed from the first container to the second container; and a pressure reduction device by means of which a pressure difference between the first container and the second container is controllably variable. | 03-19-2009 |
Carsten Ohlfest, Gluckstadt DE
Patent application number | Description | Published |
---|---|---|
20120014757 | Arrangement For Noise Reduction In Vacuum Systems - The present invention relates to an arrangement for adapting the transportation behaviour of material to be conveyed, which arrangement comprises a first container, which is coupleable to a first pressure level; a second container, which is coupleable to a second pressure level; a connecting line for transporting material to be conveyed from the first container to the second container; and a pressure reduction device by means of which a pressure difference between the first container and the second container is controllably variable. | 01-19-2012 |
John Ohlfest, Minneapolis, MN US
Patent application number | Description | Published |
---|---|---|
20160068533 | IMMUNOMODULATORS AND IMMUNOMODULATOR CONJUGATES - The invention provides compounds of formula I: | 03-10-2016 |
John Ohlfest, St. Paul, MN US
Patent application number | Description | Published |
---|---|---|
20140212442 | IMMUNOMODULATORS AND IMMUNOMODULATOR CONJUGATES - The invention provides compounds of formula I: wherein R1-R3, Ra, and Rb have any of the values defined herein, and salts thereof. The compounds have immunomodulatory properties. | 07-31-2014 |
John Ohlfest, Roseville, MN US
Patent application number | Description | Published |
---|---|---|
20150191525 | OX40L FUSION PROTEIN FOR THE IMMUNOTHERAPY OF TUMORS OF VETERINARY ANIMALS - Provided is an isolated recombinant polypeptide comprising an immunoglobulin domain and a canine OX40L extracellular domain polypeptide fragment or a biological equivalent thereof and compositions comprising: an isolated recombinant polypeptide comprising an immunoglobulin domain and a canine OX40L extracellular domain polypeptide fragment; and a pharmaceutically acceptable carrier. Also provided are methods for treating or ameliorating the symptoms of cancer in a canine comprising administering an effective amount of the isolated recombinant polypeptide of the disclosure and/or a composition of the disclosure to a canine in need thereof. | 07-09-2015 |
John R. Ohlfest, Saint Paul, MN US
Patent application number | Description | Published |
---|---|---|
20130323300 | THERAPEUTIC COMPOSITION FOR TREATMENT OF GLIOBLASTOMA - The present invention is directed to compositions and methods for treating an animal diagnosed with Glioblastoma multiforme (GBM). | 12-05-2013 |
John R. Ohlfest, Minneapolis, MN US
Patent application number | Description | Published |
---|---|---|
20130224202 | SINGLE-CHAIN VARIABLE FRAGMENT ANTI-CD133 ANTIBODIES AND USES THEREOF - Disclosed herein are a monoclonal antibody that specifically binds to human CD 133 and single-chain variable fragments thereof. Also disclosed herein is a hybridoma that produces the monoclonal antibody that specifically binds to human CD133. | 08-29-2013 |
20130331546 | ANNEXIN II COMPOSITIONS AND METHODS - The present invention provides compositions and methods that involve the 36 kDa annexin II monomer, which has been identified as having immunostimulatory properties. Accordingly, in one aspect, the invention provides compositions that include at least one 36 kDa annexin II monomer or an immunomodulatory fragment thereof. In another aspect, the invention provides methods that include administering to a subject a composition that includes at least one 36 kDa annexin II monomer or an immunomodulatory fragment thereof. In another aspect, the invention provides methods that induce an in situ increase in the 36 kDa annexin II monomer by administering to a subject an amount of composition effective to induce localized hypoxia sufficient to cause a localized increase in annexin II. | 12-12-2013 |
20150283244 | SEMI-SOLID DELIVERY SYSTEMS - The invention provides semi-solid systems for delivering biologically active materials that include a polymer comprising 1) one or more units of formula Ia, IIa, or IIIa: (formula Ia, IIa, IIIa) and 2) one or more units comprising polycaprolactone; wherein R and R | 10-08-2015 |
Karen H. Ohlfest, Roseville, MN US
Patent application number | Description | Published |
---|---|---|
20130323300 | THERAPEUTIC COMPOSITION FOR TREATMENT OF GLIOBLASTOMA - The present invention is directed to compositions and methods for treating an animal diagnosed with Glioblastoma multiforme (GBM). | 12-05-2013 |
20150283244 | SEMI-SOLID DELIVERY SYSTEMS - The invention provides semi-solid systems for delivering biologically active materials that include a polymer comprising 1) one or more units of formula Ia, IIa, or IIIa: (formula Ia, IIa, IIIa) and 2) one or more units comprising polycaprolactone; wherein R and R | 10-08-2015 |
Karen Himmel Ohlfest, Minneapolis, MN US
Patent application number | Description | Published |
---|---|---|
20130224202 | SINGLE-CHAIN VARIABLE FRAGMENT ANTI-CD133 ANTIBODIES AND USES THEREOF - Disclosed herein are a monoclonal antibody that specifically binds to human CD 133 and single-chain variable fragments thereof. Also disclosed herein is a hybridoma that produces the monoclonal antibody that specifically binds to human CD133. | 08-29-2013 |